Double Medical Technology

Double Medical Technology EBITDA per Share

The EBITDA per Share of Double Medical Technology (002901.SZ) as of Oct 16, 2026 is 1.77 CNY. In the previous year, EBITDA per Share was 1.14 CNY — a change of 55.20% (higher).

EBITDA per Share

1.77CNY

YoY

55.20%

Last updated:

EBITDA per Share of Double Medical Technology is 2025 1.77 CNY. EBITDA per Share of Double Medical Technology was 2024 1.14 CNY. It decreases by 55.20% higher compared to the previous year.

The Double Medical Technology EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1.13 CNY
Jan 1, 2019
1.44 CNY
Jan 1, 2020
1.82 CNY
Jan 1, 2021
2.05 CNY
Jan 1, 2022
0.43 CNY
Jan 1, 2023
0.34 CNY
Jan 1, 2024
1.14 CNY
Jan 1, 2025
1.77 CNY
The Double Medical Technology EBITDA per Share history
YEAREBITDA per ShareYoY
1.77CNY+55.20%
1.14CNY+239.96%
0.34CNY-22.62%
0.43CNY-78.90%
2.05CNY+12.57%
1.82CNY+26.70%
1.44CNY+27.12%
1.13CNY+23.48%
0.92CNY+29.23%
0.71CNY+30.55%
0.54CNY+33.29%
0.41CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Double Medical Technology Stock analysis

What does Double Medical Technology do? Double Medical Technology Inc, listed on the Shenzhen Stock Exchange under ticker 002901.SZ, operates in the Health Care sector with a focus on medical consumables. Headquartered in Xiamen, China, the company employs 3,793 full-time staff. It completed its initial public offering (IPO) on September 22, 2017. Double Medical Technology engages in the production, research and development, and sale of medical consumables, including orthopedic trauma implant materials, spinal implant materials, and nerve surgical implant materials. The company also manufactures surgical instruments. Its products are distributed both domestically within China and internationally. The firm's website is http://www.double-medical.com/. As a publicly traded entity, it provides medical products essential for surgical procedures and patient care, operating within the healthcare industry framework. The company's operations are centered around the development and supply of specialized medical devices and consumables, targeting healthcare providers and institutions globally. Double Medical Technology maintains a presence in both domestic and international markets, reflecting its strategic approach to market expansion and product distribution. Double Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Double Medical Technology stock

EBITDA per Share of Double Medical Technology is 1.77 CNY in 2025.

EBITDA per Share of Double Medical Technology changed from 1.14 CNY to 1.77 CNY, representing a 55.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Double Medical Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Double Medical Technology

All Key Metrics — Double Medical Technology